Fig. 2From: Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patientsEstimates of the clinical outcome were made among patients who were stratified on the basis of DNAH mutations. Subgroups were compared with the log-rank test. The Kaplan–Meier analyses of overall survival (a), progression-free survival (b), fluoropyrimidine-free survival (c), and platinum-free survival of individuals (d) with gastric cancer in TCGA are shownBack to article page